Nine Chapters Capital Management’s Allergan plc AGN Stock Holding History

Nine Chapters Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-9,100	Closed	-$2.47M	–	725
2015 Q3	$2.47M	Sell	9,100 -400	-4%	-$123K	0.22%	121
2015 Q2	$2.88M	Buy	+9,500	New	+$2.83M	0.24%	99
2014 Q3	–	Sell	-12,700	Closed	-$2.83M	–	1247
2014 Q2	$2.83M	Sell	12,700 -1,800	-12%	-$373K	0.23%	115
2014 Q1	$2.98M	Sell	14,500 -4,700	-24%	-$931K	0.35%	57
2013 Q4	$3.23M	Buy	+19,200	New	+$3M	0.32%	67

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Nine Chapters Capital Management's AGN Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 9,100 shares — an estimated $2.47M sold.

Nine Chapters Capital Management first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $3.23M in Q4 2013. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Nine Chapters Capital Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 9,100 Allergan plc shares in Q4 2015, an estimated $2.47M.
Nine Chapters Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 5 quarters.
Nine Chapters Capital Management's Allergan plc position peaked at $3.23M in Q4 2013.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.